SNAC: the absorption enhancer that makes oral semaglutide possible
Oral semaglutide (Rybelsus) is unusual in pharma: it's a peptide drug delivered by tablet. The reason it works is a co-formulated absorption enhancer called SNAC — sodium N-(8-(2-hydroxybenzoyl)amino)caprylate. The biology of how SNAC works explains why the 30-minute fast rule is so strict.
The challenge SNAC solves
Peptides are catastrophically bad oral drugs. Three barriers:
- Stomach acid (pH ~1.5) denatures the folded peptide structure.
- Gastric and intestinal proteases (pepsin, trypsin, chymotrypsin) chop the chain into fragments.
- Epithelial barrier in stomach and intestine doesn't pass molecules larger than ~500 Da efficiently. Semaglutide is ~4,114 Da.
A peptide swallowed without help would be reduced to amino acids before absorption. SNAC addresses #1 and #3 (#2 by extension).
What SNAC does, biochemically
SNAC is salcaprozate sodium — a caprylic acid derivative with a salicylate-amide group. In a tablet co-formulated with semaglutide, it does two things simultaneously upon dissolution:
- Local pH buffering. SNAC raises the local pH around the dissolving tablet to ~6–7, briefly creating a small zone (perhaps 1 cm² across the gastric mucosa) where pepsin is inactivated. Semaglutide in this pocket is not being degraded.
- Membrane perturbation. SNAC is amphiphilic — one end interacts with water, the other with lipid. It transiently inserts into the gastric epithelium and increases its permeability, particularly for medium-to-large peptide molecules. The mechanism appears to be a combination of paracellular gap loosening and direct transcellular transport.
The result: a few percent of the semaglutide in the tablet crosses the gastric wall intact and enters circulation. Bioavailability is ~1%, but it's consistent enough to be clinically useful.
Why the window is so narrow
SNAC's effects are spatially local and temporally brief. The "pocket" forms as the tablet dissolves and disperses, peaks within 5–15 minutes, and collapses by ~30 minutes:
- SNAC concentration drops as the tablet dissolves into more gastric volume, dilution decreases its local effect.
- Gastric motility moves the pocket. Even mild peristalsis disrupts the localized zone.
- Membrane permeability reverses — the epithelium reseals once SNAC concentration drops below threshold.
Why food breaks the window
Three mechanisms:
- Dilution. A glass of water doubles gastric volume and halves SNAC concentration.
- pH disruption. Acidic foods (coffee, juice, anything fermented) re-acidify the pocket; alkaline foods alter it differently. Either way, the buffered zone is gone.
- Motility. Food triggers strong gastric mixing and emptying. The tablet, partly dissolved, gets shuffled around the stomach instead of staying parked against the epithelium.
The dose-volume mystery
People sometimes ask why Rybelsus 14 mg has therapeutic effect when the injectable dose is 1.0 mg weekly. The answer is bioavailability — 1% oral × 14 mg daily = 0.14 mg/day systemic, which over 7 days totals 0.98 mg/week of systemic exposure. Roughly equivalent to the 1.0 mg injectable.
What's next after SNAC
SNAC has limits: the 30-minute window is strict, dose-to-dose variability is high, and the bioavailability ceiling is around 1–2%. Several next-generation absorption enhancers are in development. None has yet matched the consistent clinical results of SNAC.
The other path: small-molecule GLP-1 agonists that aren't peptides at all. Orforglipron is the leading candidate — it doesn't need SNAC because it isn't a peptide.
FAQ
Is SNAC absorbed into the bloodstream?
Yes, a small fraction enters circulation. Systemic SNAC is well-tolerated; long-term studies show no consistent adverse signal. Most of the SNAC stays in the GI tract and is metabolized locally.
Can SNAC be used with other peptides?
In development. SNAC-formulated oral insulin, oral PYY, and other peptides are in clinical trials. None has reached commercial release yet — the formulation is non-trivial and bioavailability for each drug is different.
Why does Rybelsus have to be the first thing in the morning?
Pure logistics. The 30-minute empty-stomach window is easiest in the morning, before food and coffee. Taking it at other times of day is possible but requires the same fasted state, which is harder to maintain.
Is SNAC safe long-term?
The chronic-toxicity studies in support of Rybelsus approval showed no serious effects. The molecule is structurally similar to medium-chain fatty acids common in food. Confidence is medium-high; truly long-term data (10+ years) will accumulate over the next decade.
Related reading
Enforce the SNAC window automatically
Peptide Protocol schedules your Rybelsus dose, starts the 30-minute window, and unlocks the food log only when SNAC has done its job.
Get the iPhone app →Informational and educational only. Not medical advice. Consult a licensed clinician before starting, changing, or stopping any peptide protocol. Mentions of investigational, compounded, or research-use peptides are for informational purposes; many such substances are not FDA-approved for human use.